Understanding Enzalutamide: A Key Player in Advanced Prostate Cancer Therapy
Prostate cancer is one of the most common cancers among men worldwide. While it often grows slowly and can be managed effectively in its early stages, advanced prostate cancer (APC) poses a significant therapeutic challenge. As the cancer progresses, it becomes more resistant to conventional treatments, leading to poorer prognosis and lower survival rates. Among the groundbreaking treatments for advanced prostate cancer, Enzalutamide stands out as a vital player. This article explores the mechanism, uses, side effects, and ongoing advancements related to Enzalutamide in prostate cancer therapy. What Is Enzalutamide? Enzalutamide, sold under the brand name Xtandi , is an oral medication that plays a critical role in the management of advanced prostate cancer, specifically castration-resistant prostate cancer (CRPC). CRPC is a form of prostate cancer that continues to grow despite the reduction of testosterone levels in the body, a common treatment approach know...